3001 Medical announces R&D focus

3001 Medical -- a recently launched developer of virtual reality (VR) medical products -- plans to focus on R&D development of a head mounted display for medical imaging and procedure guidance along with other technologies, the company said.

3001 Medical's imaging display technology is built to enable physicians to display patient-specific radiological images directly in their field of view when performing medical procedures. Future development could possibly lead to decreases in complication rates associated with a wide variety of medical procedures, such as vascular access, bedside procedures, percutaneous biopsies, aspirations, and device placements, according to the company.

"Our primary aim is to bring a cost-effective, head-mounted medical imaging display to market. Our proprietary visualization technology will have applications in virtually every medical specialty, and will provide physicians performing procedures what is analogous to `x-ray vision'," said William Mills, MD, 3001 Medical president. He added, "Being able to see a patient's internal structures before placing a needle through a patient's skin will offer dramatic advantages in efficiency, and cost-effectiveness, will ultimately improve patient safety."
3001 Medical is a division of VR technology company 3001 AD, LLC.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.